{"This": [0], "chapter": [1], "describes": [2], "the": [3, 11, 59, 75, 81], "design,": [4], "main": [5], "findings,": [6], "relevance,": [7], "and": [8, 25, 66, 78], "limitations": [9], "of": [10, 45, 64, 71, 83, 91], "landmark": [12], "Prostate": [13], "Cancer": [14], "Prevention": [15], "Trial": [16], "(PCPT),": [17], "which": [18], "randomized": [19], "men": [20, 49], "to": [21, 95], "finasteride": [22, 76], "versus": [23], "placebo": [24], "followed": [26], "them": [27], "for": [28], "7": [29], "years.": [30], "It": [31], "found": [32], "a": [33, 42], "major": [34], "reduction": [35], "in": [36, 48], "prostate": [37, 52], "cancer": [38, 47, 85], "incidence": [39], "but": [40], "also": [41], "higher": [43], "proportion": [44], "high-risk": [46, 84], "diagnosed": [50], "with": [51], "cancer.": [53], "The": [54], "study": [55], "did": [56], "not": [57, 87], "address": [58], "more": [60], "important": [61], "oncological": [62], "outcomes": [63, 73], "disease-specific": [65], "overall": [67], "survival.": [68], "Secondary": [69], "analyses": [70], "PCPT": [72, 94], "favored": [74], "arm": [77], "suggested": [79, 99], "that": [80], "risk": [82], "is": [86], "increased.": [88], "Linkage": [89], "analysis": [90], "participants": [92], "from": [93], "Medicare": [96], "claims": [97], "data": [98], "no": [100], "adverse": [101], "long-term": [102], "cardiac,": [103], "endocrine,": [104], "or": [105], "sexual": [106], "effects.": [107]}